Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
Moodys
Farmers Insurance
QuintilesIMS
AstraZeneca
Teva
Queensland Health
US Army
Julphar

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018536

« Back to Dashboard

NDA 018536 describes XENON XE 127, which is a drug marketed by Mallinckrodt and is included in one NDA. Additional details are available on the XENON XE 127 profile page.

The generic ingredient in XENON XE 127 is xenon xe-127. There are eleven drug master file entries for this compound. Additional details are available on the xenon xe-127 profile page.
Summary for 018536
Tradename:XENON XE 127
Applicant:Mallinckrodt
Ingredient:xenon xe-127
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:GAS;INHALATIONStrength5mCi/VIAL
Approval Date:Oct 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:GAS;INHALATIONStrength10mCi/VIAL
Approval Date:Oct 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
McKinsey
Colorcon
Express Scripts
Merck
AstraZeneca
Queensland Health
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot